The general transcription factor TFIID facilitates recruitment of the transcription machinery to gene promoters and regulates initiation of transcription by RNA polymerase II. hTAFII130, a component of TFIID, interacts with and serves as a coactivator for multiple transcriptional regulatory proteins, including Sp1 and CREB. A yeast two-hybrid screen has identified an interaction between hTAFII130 and heterochromatin protein 1 (HP1), a chromatinassociated protein whose function has been implicated in gene silencing. We find that hTAFII130 associates with HP1 in an isoformspecific manner: HP1␣ and HP1␥ bind to hTAFII130, but not HP1␤. In addition, we show that endogenous hTAFII130 and components of TFIID in HeLa nuclear extracts associate with glutathione Stransferase-HP1␣ and -HP1␥. hTAF II 130 possesses a pentapeptide HP1-binding motif, and mutation of the hTAFII130 HP1 box compromises the interaction of hTAFII130 with HP1. We demonstrate that Gal4-HP1 proteins interfere with hTAFII130-mediated activation of transcription. Our results suggest that HP1␣ and HP1␥ associate with hTAFII130 to mediate repression of transcription, supporting a new model of transcriptional repression involving a specific interaction between a component of TFIID and chromatin. T he general transcription factor TFIID, through the activities of its composite TATA-binding protein (TBP) and TBPassociated factors (TAF II s), plays a central role in the regulation of transcription by RNA polymerase II (reviewed in refs. 1-4). TAF II s participate in transcription by serving as molecular integrators of signals mediated by site-specific transcription factors, assisting in promoter recognition, enzymatically modifying target proteins, and facilitating the nucleation of the preinitiation complex formation. A plethora of biochemical and genetic data support the notion that TAF II s function at the interface between gene-specific transcriptional regulators and general transcription machinery.
The general transcription factor TFIID facilitates recruitment of the transcription machinery to gene promoters and regulates initiation of transcription by RNA polymerase II. hTAFII130, a component of TFIID, interacts with and serves as a coactivator for multiple transcriptional regulatory proteins, including Sp1 and CREB. A yeast two-hybrid screen has identified an interaction between hTAFII130 and heterochromatin protein 1 (HP1), a chromatinassociated protein whose function has been implicated in gene silencing. We find that hTAFII130 associates with HP1 in an isoformspecific manner: HP1␣ and HP1␥ bind to hTAFII130, but not HP1␤. In addition, we show that endogenous hTAFII130 and components of TFIID in HeLa nuclear extracts associate with glutathione Stransferase-HP1␣ and -HP1␥. hTAF II 130 possesses a pentapeptide HP1-binding motif, and mutation of the hTAFII130 HP1 box compromises the interaction of hTAFII130 with HP1. We demonstrate that Gal4-HP1 proteins interfere with hTAFII130-mediated activation of transcription. Our results suggest that HP1␣ and HP1␥ associate with hTAFII130 to mediate repression of transcription, supporting a new model of transcriptional repression involving a specific interaction between a component of TFIID and chromatin.
T he general transcription factor TFIID, through the activities of its composite TATA-binding protein (TBP) and TBPassociated factors (TAF II s), plays a central role in the regulation of transcription by RNA polymerase II (reviewed in refs. 1-4). TAF II s participate in transcription by serving as molecular integrators of signals mediated by site-specific transcription factors, assisting in promoter recognition, enzymatically modifying target proteins, and facilitating the nucleation of the preinitiation complex formation. A plethora of biochemical and genetic data support the notion that TAF II s function at the interface between gene-specific transcriptional regulators and general transcription machinery.
Human TFIID, composed of TBP and 13 associated TAF II s, is required for activator-dependent transcription in vitro. hTAF II 130 and its Drosophila homologue dTAF II 110 directly contact the glutamine-rich activation domains of Sp1 and function as Sp1's coactivator (5) (6) (7) . dTAF II 110 and hTAF II 130 also interact with the Q2 activation domain of the cAMP-responsive transcription factor CREB and mediates its activation function (7) (8) (9) . In addition, hTAF II 130 increases transcriptional activation by the retinoic acid, vitamin D3, and thyroid hormone receptors without directly contacting their activation domains (10) .
We have mapped the domains of hTAF II 130 that interact with Sp1 and CREB to the central glutamine-rich regions (refs. 11 and 12, Fig. 1A Modulation of chromatin structure plays a fundamental role in gene expression because transcription factors must contend with the nucleosomes, which are generally inhibitory to transcription. Genetic and biochemical approaches have led to the discovery of multiple transcription factor complexes that are thought to activate or repress transcription by targeting histones or nucleosomes (reviewed in refs. [19] [20] [21] . A diverse array of posttranslational modifications is made to the core histone tails that are thought to bring about distinct events affecting gene expression (reviewed in refs. 22 and 23) . It has been proposed that histone N-terminal modifications serve as a code to recruit specific proteins to the chromatin template and regulate gene expression (24) . Recent findings have implicated a functional link between TFIID and chromatin components. Several TAF II s in TFIID contain histone-like motifs (18, 25) , and the largest TAF II 250 subunit possesses acetyltransferase (26) and ubiquitinconjugating activities (27) that target histones and likely contribute to alterations in chromatin structure and facilitation of transcription. Furthermore, the bromodomains of TAF II 250 have been shown to bind to the acetylated tails of histone H4 (28) . Here, we report that hTAF II 130 interacts with certain isoforms of HP1, a chromatin-associated protein whose function has been implicated in gene silencing. We have examined the interaction of HP1 with hTAF II 130 in the context of TFIID and analyzed the effect of HP1 on transcriptional activation mediated by hTAF II 130. Our results support the notion that hTAF II 130 mediates transcriptional repression through an interaction with HP1.
Methods
Yeast Two-Hybrid Methods. The Brent yeast two-hybrid system (29) was used to screen a HeLa cell cDNA library in pJG4-5 (a gift from M. Garabedian, New York University School of Medicine) with hTAF II 130N͞C in pEG202 as bait (12) in the yeast strain EGY188 carrying the reporter plasmid pJK103. High-efficiency transformation of the library plasmids using TRAFO protocol (30) yielded 7.5 ϫ 10 6 colonies that were plated on selective media and plates containing 5-bromo-4-chloro-3-indolyl ␤-D-galactoside. Blue colonies were picked and their pJG4-5 plasmids were isolated by yeast DNA miniprep protocol and electroporated into the KC8 (Trp Ϫ ) bacterial strain, as described (31) . Restriction digests were performed to confirm the presence of library inserts in pJG4-5, and positive clones were sequenced.
Plasmids. Glutathione S-transferase (GST)-HP1 fusions were generated by PCR amplification of HP1 coding sequence and ligation into the vector pGEX-4T-1 by using EcoRI and XhoI. DNA templates used for amplification of HP1␣ and HP1␥ were pJG4-5 HeLa cDNA library plasmids isolated from the yeast two-hybrid screen. An expressed sequence tag clone containing the coding sequence of HP1␤ (GenBank accession no. BE315541) was used as template. HP1␥⌬N lacking the Nterminal 70 amino acids and HP1␥⌬C lacking the C-terminal 25 amino acids were constructed by PCR amplification of corresponding DNA fragments. All DNA constructs generated by PCR were sequenced. The same HP1 DNA fragments were subcloned into pcDNA3.1-HA-Gal4 (1-94) for expression in mammalian cells. CMV-LexA-hTAF II 130N͞C was constructed by subcloning a DNA fragment encoding hTAF II 130N͞C into pCS2ϩ expression vector containing LexA DBD (ref. 32; a gift from K. Struhl, Harvard Medical School, Boston). For in vitro translation, hTAF II 130 (1-947) and derivatives were subcloned into the vector pT␤STOP (33) . hTAF II 130N͞C-DE was generated by using QuikChange Site-Directed Mutagenesis Kit (Stratagene) with the following oligonucleotides harboring the mutation (underlined). 5Ј-GTTGACGCAGACACCTATGGACG-CCGAGCGGCAGCCTCACAAC-3Ј and 5Ј-GTTGTGAG-GCTGCCGCTCGGCGTCCATAGGTGTCTGCGTCAAC-3Ј. Mutant clones were identified by the loss of NcoI cleavage site.
GST Pull-Down Assays. All GST fusion proteins were made in the low protease Escherichia coli strain SG1117 (a gift from H. Samuels, New York University School of Medicine). E. coli cultures were grown to an OD 600 of Ϸ0.6, induced with isopropyl thio-␤-D-galactoside for 45 min at 30°C and resuspended in HEMG buffer [25 S]methionine-labeled proteins were synthesized by using the TNT-coupled reticulocyte lysate system (Promega). Radiolabeled lysate (5-10 l) was added to each binding reaction containing 1-2 g of purified GST protein in 200 l of YE buffer [150 mM NaCl͞20 mM Hepes, pH 7.4͞10% (vol/vol) glycerol͞0.05% BSA͞0.05% Nonidet P-40] (34). The reactions were carried out at 4°C for 2-3 h with nutation. After five washings with YE buffer, bound proteins were separated by SDS͞PAGE and analyzed by autoradiography. Experiments to identify endogenous TFIID components associating with GST-HP1 resins used mininuclear extracts (35) prepared from HeLa cells stably transfected with a control plasmid or a plasmid expressing inducible HA-hTAF II 130 (1-947) (a gift from S. Giannakopoulos, New York University School of Medicine). One milligram of nuclear extract prepared from induced (removal of doxycycline) or uninduced (growth in 30 ng͞ml doxycycline) cells was incubated with each resin for 3 h with nutation at 4°C. After five washings in YE buffer, bound proteins were separated by SDS͞PAGE, transferred onto nitrocellulose membrane, and sequentially probed with the following antibodies: ␣-HA (12CA5), ␣-hTAF II 130, ␣-hTAF II 250, ␣-hTAF II 100 (␣-hTAF II antibodies were gifts from E. Wang, University of Washington, Seattle). ␣-hTBP (SL39, a gift from N. Hernandez, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY) was used in a separate experiment. Immunoreactive bands were detected with an Enhanced ChemiLuminescence kit (Amersham Pharmacia).
Transfection Assays. Transient transfections were performed by using the calcium phosphate precipitation method in 35-mm tissue culture dishes of subconfluent HeLa cells that had been passaged 1 day before transfection. The total DNA per transfection was 3 g. The mammalian expression plasmids used were: pcDNA3.1-HA-Gal4 (1-94) fused to HP1␣, HP1␤, HP1␥, or HP1␥⌬C, and CMV-hTAF II 130N͞C (12) or CMV-LexAhTAF II 130N͞C. 0.5 g of the 2XGal͞2XLex-E1bTATA-luciferase reporter plasmid (32) (a gift from K. Struhl, Harvard Medical School, Boston) was cotransfected with 50 ng of LexAhTAF II 130N͞C and 50 ng of the Gal4-HP1 expression plasmids. Comparable levels of protein expression were confirmed by immunoblotting. Luciferase assays were performed as described (12) . Data shown are from a representative experiment carried out a minimum of three times.
Results

Identification of an Interaction Between hTAFII130 and HP1.
To gain further insight into the functions of hTAF II 130, we set out to identify hTAF II 130-interacting proteins by using a yeast twohybrid screen. The bait was composed of the central domain of hTAF II 130 including four glutamine-rich regions and CI fused to the LexA DNA-binding domain (LexA-hTAF II 130N͞C, Fig.  1 A) . We knew from previous studies that hTAF II 130N͞C fragment interacted positively with the activation domains of Sp1 and CREB, which served as positive controls (11, 12) . Approximately 7.5 ϫ 10 6 transformants were screened from a HeLa cell cDNA library and, unexpectedly, clones encoding human HP1␣ or HP1␥ were each isolated six times (Fig. 1B) .
The HP1 family, composed of three isoforms (␣, ␤, and ␥) in mammals, are chromatin-associated factors, whose Drosophila homologue has a well established function in epigenetic silencing (36) . The three mammalian isoforms of HP1 exhibit distinct localization in the nucleus: HP1␣ and ␤ localize predominantly to heterochromatin, and HP1␥ localizes to both heterochromatin and euchromatin (ref. 37 and references therein). Although earlier studies have implicated HP1 in the regulation of chromatin structure through interactions with proteins in heterochromatin, HP1 also has been found to associate with euchromatic regions where it may play a more dynamic role in the regulation of gene expression (reviewed in refs. 38 and 39) .
The multiple isolates of HP1␣ (three unique clones isolated two times each) and HP1␥ (five unique clones) shared a common region corresponding to the ''chromoshadow domain'' of HP1. The chromoshadow domain shares sequence homology with the chromodomain that lies near the N terminus of HP1. Chromodomains have been identified in many factors that affect gene expression and chromatin structure (39) , whereas the chromoshadow domain is unique to HP1 (40) . To define further the region of HP1␥ required for interaction with hTAF II 130, we performed binding studies by using an in vitro-translated and -radiolabeled hTAF II 130 polypeptide fragment that had been used as bait in the yeast two-hybrid screen (Fig. 2) . hTAF II 130N͞C was retained on GST-HP1␥ resin but not on GST alone (Fig. 2B, lanes 2, 4, 6 , and 9). Deletion of the C-terminal 25 residues of HP1␥ (HP1␥⌬C) that truncated the chromoshadow domain abrogated the interaction (lanes 8 and 9). In contrast, deletion of the N-terminal 70 residues encompassing the entire chromodomain (HP1␥⌬N) had no effect on binding of hTAF II 130N͞C to HP1␥ (lanes 4 and 5). Comparable amounts of GST proteins were used in all experiments (data not shown). These results indicate that the chromoshadow domain is essential for the interaction with hTAF II 130, consistent with the findings from the yeast two-hybrid screen.
A Pentapeptide Motif in hTAFII130 Is Important for Interaction with HP1␥. By using immobilized GST-HP1␥ and in vitro-translated derivatives of hTAF II 130, we set out to identify the region of hTAF II 130 that is important for interaction with GST-HP1␥ (Fig. 3A) . Significantly, a derivative of hTAF II 130, slightly smaller than hTAF II 130N͞C, corresponding to the central 278 residues (M278) failed to interact with GST-HP1␥. By contrast, derivative C321 containing the C-terminal 321 residues efficiently bound to HP1␥. Based on the retention patterns of hTAF II 130N͞C, M278 and C321, we identified a region (residues 627-700) near the C terminus of hTAF II 130N͞C that was essential for interaction with GST-HP1␥ (Fig. 3A) . In addition, we found that CII was dispensable for the interaction, but its presence increased the binding of hTAF II 130 to the GST-HP1␥ up to five-fold. The N terminus of hTAF II 130 did not contribute to the interaction with HP1␥, and the N-terminal 275 residues (N275) did not interact with HP1␥. Studies have shown that HP1 interacts with the transcriptional corepressor TIF-1␤͞KAP-1 and the p150 subunit of the chromatin assembly factor-1 (CAF-1) through a pentapeptide motif termed an ''HP1 box'' (41, 42) . Inspection of the amino acid sequence of the C-terminal region of hTAF II 130N͞C overlapping with the derivative C321 identified a pentapeptide sequence (PMVAL) resembling the HP1 box (consensus PXVXL, where X is any amino acid). We compared known HP1-interacting proteins and their HP1 boxes with the potential hTAF II 130 HP1 box (ref. 43 , Fig. 3B ). Mutations that changed the conserved residues within the HP1 box from hydrophobic to charged residues have been shown to compromise their binding to HP1 (44) . To address directly whether the potential hTAF II 130 HP1 box is important for interaction with HP1␥, we mutated the pentapeptide motif from the wild-type sequence of PMVAL to PMDAE (Fig. 3B) . Mutation of the hTAF II 130 HP1 box in the context of hTAF II 130N/C (to create hTAF II 130N͞C-DE) dramatically reduced its ability to bind to GST-HP1␥, indicating that the HP1 box is critical for the interaction between hTAF II 130N͞C and HP1␥ (Fig. 3C ).
hTAFII130 Exhibits Differential Binding to the Three HP1 Isoforms.
Intrigued by our isolation of multiple clones of HP1␣ and HP1␥ but not HP1␤ in the yeast two-hybrid screen, we sought to determine if hTAF II 130 exhibits preferences for interacting with the HP1 isoforms. We generated GST fusions of full-length HP1␣, HP1␤, and HP1␥ and examined their ability to bind to in vitro-translated hTAF II 130 (Fig. 3D) . hTAF II 130 (1-947) was efficiently retained by GST-HP1␣ and GST-HP1␥ but not by GST-HP1␤ (lanes 2-4) . hTAF II 105, a human TAF II closely related to hTAF II 130 (14) , did not bind to the three GST-HP1 resins (data not shown), consistent with the lack of an apparent HP1 box in hTAF II 105.
Also, we have detected the association of BRG1, an ATPase subunit of the mammalian SWI͞SNF complex reported to bind to HP1␣ (45) , with all three isoforms of HP1 as determined by immunoblotting (data not shown). Mass spectrometric analysis of HeLa nuclear proteins retained by the GST-HP1 resins but not by GST-HP1⌬C identified TIF-1␤͞KAP-1 (44, 45) as well as AHNAK, a 700-kDa cell cycle-regulated protein (46) as HP1-associated proteins (data not shown). Because both BRG1 and TIF-1␤ were found to associate with all three isoforms of HP1, the inability of hTAF II 130 to bind to HP1␤ is unlikely because of misfolding of HP1␤. A reciprocal binding experiment carried out with immobilized GST-hTAF II 130 (residues 410-947) demonstrated that purified recombinant HP1␣ bound specifically to hTAF II 130 (410-947) as well as to all three HP1 isoforms (data not shown), confirming HP1's ability to self-associate (47) . In summary, the in vitro binding experiments demonstrated isoform-specific interactions between hTAF II 130 and HP1.
HP1 Associates with Endogenous hTAFII130 in the Context of TFIID in a Mammalian Nuclear Extract.
Having demonstrated specific interactions between hTAF II 130 and HP1␣ and HP1␥ in vitro, we sought to examine these interactions by using endogenous material from mammalian cells. We had previously generated a HeLa cell line that stably expressed an inducible HA-tagged hTAF II 130 (1-947, HA-hTAF II 130; S. Giannakopoulos and N.T., unpublished work). Nuclear extracts prepared from a control cell line or the HA-hTAF II 130 cell line under induced and uninduced conditions were incubated with GST-HP1␥ resin. Proteins that remained bound after extensive washings were resolved by SDS͞PAGE and visualized by immunoblotting (Fig.  4A ). In the extract obtained from cells induced to overexpress HA-hTAF II 130 (Input, lane 2), HA-hTAF II 130 was retained by GST-HP1␥ (lane 8). There was no retention of HA-hTAF II 130 on the GST control resin (lane 5). To determine whether endogenous hTAF II 130 was retained by GST-HP1␥ under these conditions, we reprobed the nitrocellulose membrane with a monoclonal antibody specific for hTAF II 130 (Fig. 4A, second  panel) . A signal that corresponded to the endogenous hTAF II 130 (slightly larger than recombinant HA-hTAF II 130) was detected in all three extracts bound to GST-HP1␥ (lanes 7-9). As expected, GST alone did not retain any hTAF II 130 (lanes [4] [5] [6] .
To determine whether the other components of endogenous TFIID complex associated with GST-HP1␥, we sequentially probed the same membrane with antibodies to hTAF II 250 and hTAF II 100. We detected the recovery of endogenous hTAF II 250 and hTAF II 100 on the GST-HP1␥ resin but not on the control GST resin (Fig. 4A, third and fourth panels) . Interestingly, we observed increased recovery of endogenous TAF II s associating with GST-HP1␥ in the extracts induced for HA-hTAF II 130 expression compared with noninduced extract, suggesting that endogenous hTAF II 130 might be limiting in HeLa cells. In addition to the three TAF II components of endogenous TFIID, we also asked whether TBP could be recovered by using GST-HP1. As shown in Fig. 4B , endogenous hTBP was found to associate with GST-HP1␣ but not with GST alone. As before, the induction of HA-hTAF II 130 increased the level of hTBP associating with GST-HP1␣ (compare lanes 6 and 9). Because we did not detect direct binding of individually in vitro-translated hTAF II 250, hTAF II 100, and hTBP to GST-HP1 (data not shown), we think that the components of TFIID, through interaction with hTAF II 130, associate with GST-HP1. The observations that several endogenous TAF II s as well as TBP indirectly associate with GST-HP1 support a model in which HP1 targets hTAF II 130 in the context of TFIID.
Gal4-HP1 Fusions Repress Transcriptional Activation by hTAFII130.
To determine the functional significance of the newly discovered hTAF II 130-HP1 interaction, we performed transient transfection assays in HeLa cells. We initially examined the effects of transfected HP1 on reporter activity and found that HP1 re- 4, and 7) , and a HeLa cell line induced (lanes 2, 5, and 8) or uninduced (lanes 3, 6, and 9) for HA-hTAF II130 expression. The extracts were incubated with GST (lanes 4 -6) or GST-HP1␥ (lanes 7-9); bound proteins were analyzed by sequential immunoblotting with ␣-HA, ␣-hTAFII130, ␣-hTAFII250, and ␣-hTAFII100 antibody. Endogenous hTAF II130 is larger in size than the recombinant HA-hTAFII130, which lacks the extreme N-terminal sequence. The recombinant HA-hTAF II130 in the induced cell extract is detected in the fraction bound to HP1␥, whereas endogenous hTAF II130, hTAFII250, and hTAFII100 were detected in all three nuclear extracts bound to HP1␥. The arrowheads in the third and fourth panels correspond to HA-hTAF II130, whose signal remained after sequential immunoblotting with the monoclonal antibodies. * , nonspecific background bands.
(B) The same nuclear extracts used in A were incubated with GST or GST-HP1␣, and the bound fractions were analyzed for the presence of hTBP with ␣-hTBP antibody.
pressed hTAF II 130-mediated transcription by two-fold (data not shown). We think the modest effect is caused by the low expression levels of recombinant HP1 compared with endogenous HP1 that are abundant in cells. It is also possible that the transfected HP1 becomes associated with the endogenous protein, and only a small fraction of HP1 may be involved in transcriptional regulation at euchromatic gene promoters. Consistent with this possibility, we were unable to copurify endogenous or transfected HP1 with hTAF II 130. However, when fused to a heterologous DBD, HP1 proteins function as repressors of transcription (48, 49) . We examined whether Gal4-HP1␥ can affect hTAF II 130-mediated transcriptional activation. Transcription from the UAS-Luc reporter bearing two Gal4-binding sites was enhanced when transfected with hTAF II 130 expression plasmid in the presence of Gal4 DBD (Fig. 5A, lanes 1 and 2) . Significantly, increased transcription mediated by hTAF II 130 was dramatically reduced upon cotransfection of Gal4-HP1␥ (lane 3). This repression depended on the C-terminal domain of HP1␥ that is required for the interaction with hTAF II 130 because HP1␥⌬C truncated for this domain failed to repress hTAF II 130-mediated activation (lane 4). Gal4 DBD fused to an unrelated repressor protein LANA (50) also failed to repress transcription by hTAF II 130 (lane 5). None of the Gal4 fusion proteins affected basal transcription in the absence of hTAF II 130 (data not shown), indicating that the observed effect is specific to activation mediated by hTAF II 130.
The central domain of hTAF II 130 activates transcription when fused to a heterologous DNA-binding domain (11) . A LexAhTAF II 130N͞C fusion, containing the same hTAF II 130 subdomain used in the yeast two-hybrid screen and in vitro binding studies activated transcription from a reporter plasmid bearing two Gal4-and two LexA-binding sites (Fig. 5B, lane 2) . To examine the effects of Gal4-HP1 proteins on transcriptional activation by LexA-hTAF II 130N͞C, we cotransfected plasmids expressing Gal4 DBD fused to the three isoforms of HP1.
Gal4-HP1␣ and Gal4-HP1␥ potently inhibited LexAhTAF II 130N͞C-mediated activation, whereas Gal4-HP1␤ was not as effective in inhibiting transcription (lanes 3-5). Partial repression detected by Gal4-HP1␤ is likely caused by other mechanisms of repression mediated by HP1 involving selfassociation and͞or association with HDAC activity (39, 49 Functional Implications of hTAFII130-HP1 Interaction. HP1 proteins are abundant nonhistone chromatin-associated factors that participate in heterochromatin formation and gene silencing (reviewed in refs. 38 and 39); however, the precise mechanisms of HP1 repression are not well understood. HP1 has been shown to play a role not only in heterochromatic silencing but also in normal repression of genes in euchromatin (51) . In mammalian cells and Schizosaccharomyces pombe, it has been reported that HP1͞Swi6 chromodomain binds to histone H3 methylated by the methyltransferase SUV39H1͞Clr4 at Lys-9 (52-54). Interestingly, Rb was shown to target SUV39H1 to histone H3 and to recruit HP1, leading to transcriptional repression of the endogenous cyclin E promoter (55) . In vitro transcription assays reconstituted with chromatin and nuclear extracts have demonstrated HP1␤-dependent repression of transcription from a template methylated by SUV39H1 (56) . In this study, the authors failed to detect repression by HP1␤ in a highly reconstituted transcription system and speculated that other factors in the nuclear extract might be necessary to establish full repression. Because we find preferential association between hTAF II 130 and HP1␣ and HP1␥, it is possible that HP1␤ is insufficient to establish repression in the reconstituted transcription system.
The interaction of hTAF II 130 and HP1 may result in transcriptional repression by blocking the association of activators with components of TFIID. Alternatively, promoter-bound TFIID may be held in a repressed state by hTAF II 130-HP1 interaction. Indeed, there is increasing evidence suggesting that the general transcription factors (GTFs) are bound at promoters repressed by heterochromatin or by similar repressive protein complexes (reviewed in refs. 57 and 58). In Drosophila, chromatin-immunoprecipitation analysis of promoter regions bound by the Polycomb group (PcG) of proteins showed that repressed promoters are bound by GTFs (59) . Moreover, PcG proteins interact with GTFs in vitro, suggesting that PcG complexes may silence target gene expression by inhibiting the activation function of GTFs. Significantly, purification of a major PcG complex from Drosophila embryos has identified multiple TAF II s associating with known PcG proteins (60) . It is possible that hTAF II 130 may interact with HP1␣ and HP1␥ to facilitate the retention of TFIID in a promoter-specific manner forming repressed ''preloaded'' TFIID poised for rapid activation. The binding of site-specific activators upstream of the core promoter may compete for a surface on hTAF II 130, causing dissociation of HP1 and relieving its repressive activity.
Another intriguing possibility is that hTAF II 130-HP1 association may play a direct role in the activation of certain gene promoters by facilitating recruitment of TFIID to histones specifically modified by acetylation and methylation and bound by HP1. Structural studies have indicated that hTAF II 250 double bromodomain binds to multiple acetylated tails of histone H4 (28) . It is tempting to speculate that TFIID may be recruited to promoters bound by specifically modified histones through contacts with hTAF II 130 and hTAF II 250, an idea that is consistent with the histone code hypothesis (24) .
